Marker metabolites can be therapeutic targets as well

Adrian K. Arakaki (), Jeffrey Skolnick () and John F. McDonald
Additional contact information
Adrian K. Arakaki: Center for the Study of Systems Biology, Georgia Institute of Technology
Jeffrey Skolnick: Center for the Study of Systems Biology, Georgia Institute of Technology
John F. McDonald: School of Biology, Georgia Institute of Technology

Nature, 2008, vol. 456, issue 7221, 443-443

Date: 2008
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/456443c Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:456:y:2008:i:7221:d:10.1038_456443c

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/456443c

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().